AKT1 and breast cancer: Other studies have found that the PI3K/AKT/mTOR pathways play a role in the regulation of PD-L1 in several murine cancer models, including non-small-cell lung cancer [136], colorectal cancer [137], pancreatic cancer [138] and breast cancer [139].